Bengaluru-based precision oncology startup 4baseCare has closed its Series B funding round at Rs 128 crore, securing an additional Rs 38 crore in fresh capital led by growX Ventures, along with participation from existing investors.
The company had previously raised Rs 90 crore in January as part of the Series B round, co-led by investor Ashish Kacholia and Lashit Sanghvi, with backing from existing investor Yali Capital.
In a statement, 4baseCare said the proceeds will be used to accelerate its global expansion, strengthen its genomics laboratory network, and scale its AI-powered precision oncology platform, OncoTwin.
On the close of Series B round, 4baseCare co-founder & CEO Hitesh Goswami said, “The additional capital will help us expand our genomics lab network globally and further scale OncoTwin, our AI-based precision oncology platform, to support clinicians with deeper, real-world, clinically actionable insights.”
Founded in 2019 by Hitesh Goswami and Kshitij Rishi, 4baseCare is focused on addressing gaps in genomic data diversity that limit the effectiveness of precision cancer care for non-Western populations.
